Capsules are laid out for inspection on a production line (Photographer: Tomohiro Ohsumi/Bloomberg)
Hester Biosciences Ltd. may fall short of its Rs 140-145 crore internal sales target in the current fiscal, its Managing Director Rajiv Gandhi said.
Although the company expects its revenue to grow about 25 percent in the next fiscal, there might be a slight decline in the margins, Gandhi told BloombergQuint in an interview.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
